about
Functional organization of the basal ganglia: Therapeutic implications for Parkinson's diseaseChaperone-mediated autophagy markers in Parkinson disease brainsBiomarkers for dementia and mild cognitive impairment in Parkinson's disease.Pathophysiology of the basal ganglia in Parkinson's disease.Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.Lesion of the centromedian thalamic nucleus in MPTP-treated monkeysThe origin of motor fluctuations in Parkinson's disease: importance of dopaminergic innervation and basal ganglia circuits.Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.Motor complications in Parkinson's disease and the clinical significance of rotational behavior in the rat: have we wasted our time?Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease.Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene.The impact of silent vascular brain burden in cognitive impairment in Parkinson's disease.The relationship between atrophy and hypometabolism: is it regionally dependent in dementias?Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches.Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.Changes in subthalamic activity during movement observation in Parkinson's disease: is the mirror system mirrored in the basal ganglia?The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics.High frequency stimulation of the subthalamic nucleus and levodopa induced dyskinesias in Parkinson's disease.What can man do without basal ganglia motor output? The effect of combined unilateral subthalamotomy and pallidotomy in a patient with Parkinson's disease.Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2.How does Parkinson's disease begin? The role of compensatory mechanisms.Bilateral subthalamotomy in Parkinson's disease: initial and long-term response.Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.New MRI, 18F-DOPA and 11C-(+)-alpha-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: advantages to improve PET quantification.Local administration of sarizotan into the subthalamic nucleus attenuates levodopa-induced dyskinesias in 6-OHDA-lesioned rats.DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.From unilateral to bilateral parkinsonism: Effects of lateralization on dyskinesias and associated molecular mechanisms.Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease.Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease.Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.Cognitive dysfunction in Parkinson's disease related to the R1441G mutation in LRRK2.Pain and dyskinesia in Parkinson's disease.Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease.
P50
Q22252880-25370753-924E-4294-B731-F2002C3C85A5Q28115026-2D9231CE-FA90-4B3C-9A9D-78E1113AB177Q31097119-344282A7-507B-40E4-BB0D-D05650EA0484Q34070859-35D751AD-0650-4794-8C7B-C8D8BB16F14AQ35012627-37E5E4D9-8C37-400F-A925-20E0DEAE7701Q35477325-DF57105F-6EAE-4B8A-97C1-798A82CCF559Q35551052-F0B47A01-210D-40EE-955B-9E976C6FA8B7Q35626716-CCFAC54E-F39D-4994-8083-CD13E9998644Q36050210-FB980D62-849F-4EF1-9A14-3734688E71DEQ36352491-3FD58AA9-A9D8-4C35-8088-385BA8338CDFQ36738118-B99FD057-29F4-492D-A48B-AD2346475FAEQ37631957-7A79BFF3-557C-403E-A85D-F1F838466294Q38365994-4BC9BC51-218B-4758-8CDD-AEA38E4B6C21Q38475592-8D08C289-A0B7-4488-831A-AD7B69D61398Q38501853-BB608196-A39A-444B-8C2F-DFDA6C403340Q38555808-8D1C499C-6F9C-4A4D-B4D1-E997BC1BB0E8Q38761739-C1405808-2EF6-4C18-AD18-8ADB180DB418Q39147625-2397D2E9-F832-463E-813E-4DED0D778999Q40075849-D9D2954B-8C69-49C8-8867-CA6F3D27C2B5Q42464291-17A706A8-E8C6-45A2-9DA9-7EA3743C87E3Q42509207-7751176B-5162-4983-B427-5EA62AD9077DQ43038804-30716E9F-4CCF-413A-9B7D-4F4C87A9BDEBQ43278477-260F0595-F737-4574-99B8-ADE6F80233CCQ44350484-C913A3DF-DC06-4A03-8163-D85A4973FE97Q44809582-A9831ED4-086D-4095-822B-88F76EF61651Q45249855-FB4F3CE0-5F9A-4806-93B2-77A8219CB820Q46006187-78204916-524E-4CCB-83D3-AA02E96642D0Q46021600-B1BCEE75-2150-478D-9BF6-03D7A8E6C270Q46153193-6550DE5F-414F-420F-8B3F-8AAE821F7EE0Q47907932-C3847D6D-48CC-447B-9E20-A5583314FC8AQ48018054-8124110A-EC69-45D6-A9E1-383EFD308AF6Q48108148-00EDED9E-C3D1-436E-AB3B-1F460BBB42F2Q48116780-D0104D7F-9B72-4F0C-B2BE-C7B3A062CF8AQ48132187-0E228DFC-3154-40FC-8741-18A6FB6B6B5CQ48201163-B49EFFD9-9665-40CA-AB47-514BC6DEDEC6Q48231824-9B492C18-8A6D-41C2-9384-E995D344F74EQ48232651-97CC3982-9FFD-4B3B-87A2-58D97B272596Q48398856-75CC9A9D-C635-4BB0-A6A3-A5674C8D184DQ48416681-718D20AA-6ECE-40C2-B9F9-7FD9DAE77752Q48420339-11ED0616-105A-431A-B157-92DFEE4E164B
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Maria Cruz Rodriguez Oroz
@ast
Maria Cruz Rodriguez Oroz
@en
Maria Cruz Rodriguez Oroz
@es
Maria Cruz Rodriguez Oroz
@nl
type
label
Maria Cruz Rodriguez Oroz
@ast
Maria Cruz Rodriguez Oroz
@en
Maria Cruz Rodriguez Oroz
@es
Maria Cruz Rodriguez Oroz
@nl
altLabel
M C Rodriguez
@en
prefLabel
Maria Cruz Rodriguez Oroz
@ast
Maria Cruz Rodriguez Oroz
@en
Maria Cruz Rodriguez Oroz
@es
Maria Cruz Rodriguez Oroz
@nl
P1053
D-1490-2018
P106
P31
P496
0000-0001-5962-772X